Persistent MALT Lymphoma With Plasmacytic Differentiation Following Treatment With Rituximab

Am J Dermatopathol. 2023 May 1;45(5):337-338. doi: 10.1097/DAD.0000000000002353. Epub 2022 Dec 7.

Authors

Mohammed Moumen¹, Nathan Lewis Bowers², Robert DeSilverio Jr³, Omar P Sangueza²

Affiliations

¹ School of Medicine, Wake Forest University, Winston-Salem, NC.
² Departments of Dermatology and Pathology, Wake Forest School of Medicine, Winston Salem, NC; and.
³ Atlantic Dermatopathology, LLC, Essington, PA.

PMID: 36729805
DOI: 10.1097/DAD.0000000000002353

No abstract available

MeSH terms

Humans
Lymphoma, B-Cell, Marginal Zone* / drug therapy
Lymphoma, B-Cell, Marginal Zone* / pathology
Lymphoma, Non-Hodgkin
Rituximab / therapeutic use
Stomach Neoplasms*

Substances

Rituximab

Supplementary concepts

Familial primary gastric lymphoma